OptiNose Inc OPTN Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$9.60 unchanged at close May 21
Last close · Previous close $9.60
- Market cap
- $96.69MAt the May 21 close
- P/E ratio
- PausedOn last 12 months’ EPS
See the note under the price. - Diluted EPS
- PausedLast 12 months
See the note under the price. - Dividend yield
- NoneLast 12 months
Price chart
$9.60up $0.44, 4.80%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$9.60May 20
- Volume0.00May 21 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume67.80KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the May 21 close. Total return includes reinvested dividends.Price change only, without dividends.
| Period | OPTN |
|---|---|
| Short term | |
| 1M | OPTN: up 4.8% |
| 3M | OPTN: up 66.4% |
| YTD | OPTN: up 43.7% |
| 1Y | OPTN: down 44.8% |
| Long term | |
| 3Y | OPTN: down 67.0% −30.9% a year |
| 5Y | OPTN: down 85.3% −31.8% a year |
$10,000 invested in OPTN 5 years ago (May 21, 2020) would be worth about $1,471 at the close on , with dividends reinvested.
| Period | OPTN |
|---|---|
| Short term | |
| 1M | OPTN: up 4.8% |
| 3M | OPTN: up 66.4% |
| YTD | OPTN: up 43.7% |
| 1Y | OPTN: down 44.8% |
| Long term | |
| 3Y | OPTN: down 67.0% −30.9% a year |
| 5Y | OPTN: down 85.3% −31.8% a year |
$10,000 invested in OPTN 5 years ago (May 21, 2020) would be worth about $1,471 at the close on , not counting dividends.
All-time high
$446.40
Closing high on . Now 97.8% below that record.
Split-adjusted daily closes since Oct 13, 2017.
Stock splits
1
1-for-15 on . Share counts adjust after each split.
Valuation
The May 21 close compared with the last 12 months of reported results (the four quarters to Mar 31, 2025). Tap a metric to see how it’s calculated. Per-share results and the measures based on them are paused. See the note under the price.
Price-to-earnings (P/E)
Paused
Other valuation measures
- 1.2×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - Price-to-bookPausedBook value as of Mar 31, 2025
See the note under the price. - PEG ratioPausedLast 12 months’ EPS growth
See the note under the price. - −35.43%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $150.97MAt the May 21 close
What it would cost to buy the whole business: the market cap at the May 21 close, plus debt, minus cash and short-term investments from the Mar 31, 2025 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own OPTN DCF in Excel. Value OptiNose with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q1 FY25, the quarter ended Mar 31, 2025. “Last 12 months” means the four quarters from Apr 1, 2024 to Mar 31, 2025, and balance-sheet figures are as of Mar 31, 2025.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $81.86Mup 10.6%
- Net income
- −$29.89M
- Diluted EPS
- PausedSee the note under the price.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q2 FY23 (Jun 30, 2023) | $19.45M | $2.57M | Paused See the note under the price. |
| Q3 FY23 (Sep 30, 2023) | $19.82M | −$9.29M | Paused See the note under the price. |
| Q4 FY23 (Dec 31, 2023) | $19.87M | −$9.97M | Paused See the note under the price. |
| Q1 FY24 (Mar 31, 2024) | $14.88M | −$14.07M | Paused See the note under the price. |
| Q2 FY24 (Jun 30, 2024) | $20.49M | −$7.58M | Paused See the note under the price. |
| Q3 FY24 (Sep 30, 2024) | $20.44M | $467.00K | Paused See the note under the price. |
| Q4 FY24 (Dec 31, 2024) | $22.42M | −$360.00K | Paused See the note under the price. |
| Q1 FY25 (Mar 31, 2025) | $18.51M | −$22.42M | Paused See the note under the price. |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY20 (Dec 31, 2020) | $49.12M | −$99.79M | Paused See the note under the price. |
| FY21 (Dec 31, 2021) | $74.65M | −$82.30M | Paused See the note under the price. |
| FY22 (Dec 31, 2022) | $76.28M | −$74.83M | Paused See the note under the price. |
| FY23 (Dec 31, 2023) | $70.99M | −$35.48M | Paused See the note under the price. |
| FY24 (Dec 31, 2024) | $78.23M | −$21.54M | Paused See the note under the price. |
Margins
- Gross 90.5%
- Operating −19.3%
- Net −36.5%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$34.26MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$34.21MLast 12 months
- Capital spending$50.00KLast 12 months
- −41.9%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $55.76MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
Balance sheet
- $72.93MAs of Mar 31, 2025
Cash plus short- and long-term marketable securities on the Mar 31, 2025 balance sheet.
- Total debt$127.21MAs of Mar 31, 2025
- Net debt$54.27MAs of Mar 31, 2025
- Book value per sharePausedAs of Mar 31, 2025
See the note under the price. - 0.64As of Mar 31, 2025
Current assets divided by current liabilities on the Mar 31, 2025 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio
Financial strength
- 3 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✗Net income was positive: not passed
- ✗Operating cash flow was positive: not passed
- ✗Return on assets improved: not passed
- ✗Operating cash flow exceeded net income: not passed
- ✓Long-term debt fell relative to assets: passed
- ✗Current ratio improved: not passed
- ✗Share count didn’t rise: not passed
- ✓Gross margin improved: passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- −23.6%Last 12 months
Over the last 12 months, OptiNose’s net loss was 23.6% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About OptiNose Inc
OPTION CARE INC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Pennsylvania, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
OPTN news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
OPTN stock FAQ
What is OPTN stock’s price today?
OptiNose (OPTN) traded at $9.60 at the close on , unchanged from the previous close of $9.60.
If you invested $1,000 in OPTN 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in OPTN on would be worth about $147 at the close on , a total return of −85.3%. The same $1,000 would be worth $552 if invested one year ago. Past performance doesn’t predict future returns.
What is OptiNose’s market cap?
OptiNose’s market capitalization is about $96.7 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $9.60 (how market cap works).
How much revenue does OptiNose make?
OptiNose reported $81.9 million of revenue over the four quarters to , up 10.6% from the twelve months before. In its latest quarter (Q1 FY25, ended ) revenue was $18.5 million, up 24.4% from a year earlier.
Is OptiNose profitable?
Not over the four quarters to . OptiNose reported a net loss of $29.9 million across those four quarters on $81.9 million of revenue.
Does OPTN pay a dividend?
OptiNose hasn’t paid a dividend in the last twelve months.
What is OPTN’s all-time high?
OPTN’s highest closing price was $446.40 on , adjusted for stock splits. At $9.60 at the close on , it is 97.8% below that record.
Has OPTN stock ever split?
Yes, once: 1-for-15 on .
How has OPTN stock performed?
Including dividends and measured to the close on , OPTN has returned +43.7% so far this year and −44.8% over the past year, and −85.3% over five years (−31.8% a year). Past performance doesn’t predict future returns.
What sector and industry is OptiNose in?
OptiNose is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, and is headquartered in Pennsylvania, USA.
What exchange does OPTN trade on?
OptiNose trades on the Nasdaq under the ticker symbol OPTN. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.